Introduction
. In elderly patients undergoing coronary bypass surgery the commonest cause of death is myocardial failure [9] . Over the last 20 years there has been a steady rise in the However there is little published work on ways of spemean age of patients with ischemic heart disease presentcifically countering the negative effect of age on the ability ing for interventional therapy [1] . The early mortality for of the heart to recover from stressful cardiac interventions. elderly patients after myocardial infarction [2] , post-infarcStudies in sheep [10] , and rabbits [11] have suggested tion reperfusion [3] , angioplasty [4, 5] and cardiac surgery that the senescent myocardium has reduced tolerance to [6, 7] is up to three times greater than for younger patients, ischemic stress. The mechanisms underlying this age-reparticularly in the urgent setting. In recent years, age has lated intolerance to stress are not well understood, but risen in significance as a predictor of mortality for corimpaired mitochondrial function [12] or altered calcium onary bypass surgery [8] , and remains one of the most homeostasis with a consequent reduction in cellular energy significant predictors of failure after medical reperfusion production have been implicated [13] . Coenzyme Q 10 (CoQ ) has emerged as a serious candidate for therapeutic use in the amelioration of bioenergetic defects manifested months) female Sprague Dawley rats were randomly during senescence [16, 17] . CoQ is an integral component assigned to receive daily intraperitoneal injections for 6 10 of the mitochondrial oxidative phosphorylation system, weeks (mean 4761 days) of either CoQ (4 mg / kg) 10 being a lipid-soluble redox carrier between particular dispersed in a 2% aqueous suspension of polyoxyethylated respiratory enzyme complexes in the electron transport hydrogenated castor oil (HCO-60), or an equivalent volchain in the mitochondrial inner membrane. Therefore, ume (70-100 ml) of HCO-60. Forty-four animals comunder conditions where a reduction in mitochondrial pleted the course of treatment and 35 hearts were successrespiratory chain function underlies the bioenergetic defully isolated and perfused. Arterial blood pressure was ficiencies of cells [14, 18] , it would be anticipated that measured in the awake state using a tail cuff in subgroups administration of CoQ would ameliorate the functional of senescent and young rats (n57 per group). shortfall. The logical basis is the restoration of optimal
The dose regime for CoQ (4 mg / kg) was based on 10 rates of oxidation-reduction reactions in the respiratory reports of clinical usage in chronic trials in man [16] , and chain by enhancing the intramitochondrial concentration of on a study demonstrating improved exercise tolerance in CoQ . Indeed, CoQ is used successfully as a therapy for rats [22] . No side effects were observed. In a subgroup of 10 10 some patients with neuromuscular and other diseases senescent rats we used CoQ at one tenth of this dose (0. was then mounted on an isolated working rat heart administration of CoQ does restore depleted cardiac funcapparatus [21] and retrograde perfusion via the aorta was tion associated with senescence. In this study we have used commenced at a pressure of 95 mmHg with buffer a working heart preparation from laboratory rats [21] to equilibrated with 95% O / 5% CO . The left atrial appentest the following two central propositions: (1) that under 2 2 dage was incised and cannulated for the working mode. appropriate conditions of stressful work the hearts of old Pressure measurements were recorded (Grass Polygraph, rats are functionally debilitated compared to those of Model 7, Quincy, MA, USA). young rats; (2) that administration of CoQ to rats will 10 ameliorate age-associated functional deficits in the heart. A corollary of the second proposition is that administration of 2.3. Pacing stress CoQ should show greater benefit to hearts of old rats 10 than those of young rats. Using working heart preparations After 15 min retrograde (nonworking) perfusion the from various cohorts of laboratory rats, we first report that hearts were made to work for 15 min with a left atrial the hearts from senescent rats do show a markedly pressure of 11 mmHg and a mean aortic pressure of 74 inefficient recovery of pump function after a severe, mmHg. Myocardial work and oxygen consumption aerobic, pacing stress, compared to hearts from young rats.
(MVO ) were measured. Second, we report that pre-treatment of senescent rats with 2 Work, MVO and efficiency were calculated as follows CoQ greatly enhances the performance of their hearts 2 10 [23]: after they had been subjected to aerobic pacing stress. pressures respectively of oxygen (mmHg), 760 is the 2.6. Statistical analysis barometric pressure (mmHg), 0.024 is the solubility coefficient of oxygen in the perfusate at 378C [25] , CF is the Results are expressed as the mean6standard error of the coronary flow (ml / min), and HW is the wet heart weight mean (S.E.M.). Two-way analysis of variance (ANOVA) (g). Mechanical efficiency allows for differences in MVO 2 was used to compare differences between the groups and secondary to altered work capacity. This is calculated by determine interaction effects. Differences between group dividing the work by the MVO and expressing the result Work is expressed as mJ/s/g, and MVO as ml / min / g. 2 Recovery of work, MVO and efficiency after pacing were Following baseline assessment of work and MVO , the 2 3.1. Body and heart weight heart was returned to retrograde perfusion and subjected to a stress of 120 min of ventricular pacing (Grass SD9 Senescent rats (n519) had a significantly greater body Stimulator), at 510 beats per minute (bpm, unpaced rate weight than young rats (n516) (359.0611 vs. 28766 g: young, 24969, senescent, 20565 bpm), during Langen-P,0.0001). Senescent rats also had a significantly greater dorff mode perfusion. Coronary flow and MVO were 2 heart weight than the young (1.3560.07 vs. 0.9260.03 g: measured at 15 min intervals throughout the pacing period.
P,0.0001). The heart to body weight ratio was not Following pacing, the heart was perfused for a final 15 min significantly different between the senescent and young in the working mode. At the end of the perfusion, hearts rats (3.660.2 vs. 3.160.1 mg / g respectively: P50.055). were freeze-clamped, and stored in liquid nitrogen at There were no significant effects of CoQ treatment on 10 21908C, for later assay of high energy phosphates. heart weight, body weight or (heart weight) /(body weight). The systolic blood pressure measured by the tail 2.4. Coronary and myocardial lactate cuff method in the senescent rats (13064 mmHg) was lower than in the young rats (14763 mmHg, P,0.01). In an additional 25 rat hearts (12 young and 13 senescent), lactate release was measured to determine whether pacing stress in this preparation induced ischemia.
3.2. Cardiac work It was found that a twofold increase in heart rate to 510 bpm (resting rate approximately 230 bpm) was the maxiIn the pre-pacing period in untreated hearts, the work mum rate compatible with a stable preparation. Lactate capacity per g wet weight of senescent hearts was only release into the coronary effluent was measured at four 74% of that in young hearts (9.960.6 vs. 13.361.5 mJ / g / time points: during the pre-stress working period, 5 and 90 sec, P,0.05). In senescent hearts CoQ treatment in-10 min after the onset of pacing and finally in the post-stress creased cardiac work by 28% compared to untreated working period. Coronary effluent was collected and stored (12.760.6 vs. 9.960.6 mJ / g / sec: P,0.01) (Fig. 1) . By in pre-cooled Eppendorf tubes at 2708C, then subjected to contrast, in young hearts CoQ had no effect. After pacing 10 enzymatic assay of lactate [26] . The hearts were freezestress, cardiac work was markedly reduced in all four clamped at the end of perfusion and extracted with groups, regardless of age or treatment but especially in the perchloric acid for assay of myocardial lactate. senescent untreated group. The striking finding was that CoQ treatment in senescent hearts produced a fourfold 10 increase in post-stress work from 1.660.6 mJ/g/s to 2.5. Creatine phosphate and ATP assay 6.160.7 mJ/g/s (P,0.001) (Fig. 1 ). This level of work capacity in CoQ treated senescent hearts was just as high Frozen ventricular tissue was homogenised with 1 M 10 as that in the young hearts. CoQ treatment had no effect perchloric acid and centrifuged. The supernatant was coronary flow was significantly lower in the senescent hearts than in the pacing, hearts of senescent rats had a lower work capacity than those of young hearts (P,0.01), with no effect of treatment in either age group young rats. After pacing all groups showed reduced work levels. The (P50.9). During pacing, coronary flow was significantly less in the reduction was most marked in the untreated senescent group. CoQ 10 senescent animals compared to the young rats (P,0.0001). In senescent treatment abolished all differences in work capacity between senescent hearts coronary flow was increased by treatment with CoQ (P,0.0001). 10 and young hearts. This effect was most striking after pacing stress. *P,0.05, **P,0.01, ***P,0.001. nonworking (13.360.7 vs. 16.960.9 ml/g/ min: P,0.01) and working modes (12.960.6 vs. 18.260.8 ml / g / min: on post-stress function in young hearts (Fig. 1 ). This P,0.0001), with no significant effect of treatment in age-specific augmentation in work performance by CoQ 10 either age group (P50.9) (Fig. 3 ). was also clearly manifested when post-stress work was
The initiation of pacing increased coronary flow in all normalized in terms of pre-stress function (Fig. 2) . In groups by approximately 25%. During pacing, in untreated senescent hearts CoQ treatment improved recovery of 10 animals coronary flow was significantly less in the seneswork from 16.864.3% to 48.164.1% (P,0.0001). By cent than in the young (P,0.0001) (Fig. 3) . In senescent contrast in young hearts CoQ treatment produced no 10 hearts, treatment with CoQ was associated with increases 10 change (44.567.4 to 42.367.3%).
in coronary flow (P,0.0001) to levels similar to those seen in the young hearts. There was no effect of CoQ 10 treatment on coronary flow in the young hearts.
Coronary flow
After pacing in all four groups coronary flow was significantly lower than before pacing (P,0.0001). In Before pacing, coronary flow was significantly lower in untreated hearts post-pacing coronary flow (Fig. 3) was the senescent hearts than in the young hearts, in both the significantly lower in the senescent group than in the young (P,0.01). CoQ treatment of old rats provided 10 some benefit to post-pacing coronary flow.
MVO and efficiency

2
Before pacing MVO in untreated working senescent 2 hearts was only 66% of that in the young hearts (17468.4 vs. 262.8612.8 ml/g/min: P,0.0001) (Fig. 4) . However, despite its effect in enhancing work performance, CoQ 10 treatment did not significantly increase MVO in the 2 senescent age group compared to the untreated senescent group (195.1615.1 vs. 17468.4 ml / g / min: P50.21) (Fig.  4) . The end result of these two effects (increased work without a corresponding increase in oxygen consumption) to coronary flow with increases in all four groups (Fig. 4) . was no effect of treatment on the recovery of young hearts. *P,0.05, **P,0.01, ***P,0.001.
There was an age-specific effect of CoQ treatment on 
Aerobic nature of pacing stress
It was important to validate the aerobic nature of the pacing stress by demonstrating that pacing did not result in ischemic metabolism. Measurements of lactate in 25 rat hearts showed no significant difference in lactate release between age groups (P50.64). Before pacing there was a small amount of lactate release in both age groups (average of two groups, 1.660.2 mmol / g / min). With pacing, lactate release increased slightly in both age groups (2.360.2 mmol / g / min after 5 min and 2.860.2 mmol / g / min after 90 min) but still remained low relative to oxygen consumption and was compatible with fully aerobic metabolism even during the period of maximal stress. Lactate release MVO in the senescent animals during pacing was 9.9 2 mmol / g / min which is equivalent to 59 mmol / g / min of MVO with a significant increase in the senescent hearts, ATP. In the young hearts, the mean MVO during pacing 2 2 approaching levels seen in the young hearts (P,0.0001), was 12.1 mmol / g / min, which is equivalent to 73 mmol / g / but with no effect in young hearts. min of ATP. Thus in both groups during pacing, over 91% After pacing there was a trend towards reduced recovery of the energy requirements were met by oxidative metaboof MVO in senescent hearts compared to young hearts lism, which was similar to that during the pre-stress period 2 (61.364.0 vs. 74.165.0%: P50.06) (Fig. 2) . Recovery of (95%). This result validates the aerobic nature of the pre-pacing efficiency in senescent hearts was less than in pacing stress. Furthermore, myocardial lactate concentrayoung hearts (25.766.5 vs. 61.4612.0%: P,0.05). CoQ tion measured at the end of the post-pacing working period 10 treatment produced significant improvements in post-stress was normal and did not differ between old and young age recovery of both MVO and efficiency in senescent hearts groups (4.861.5 vs. 3.860.4 mmol / g dry weight respec-2 but had no effect in young hearts (Fig. 2) . tively, P50.65). No significant difference between the two age groups was observed for the lactate / pyruvate ratio (15.762.8 vs. 20.263.0 respectively, P50.32).
Myocardial high energy phosphate levels
Measured after recovery from pacing stress, mean levels 4. Discussion of myocardial ATP and creatine phosphate were similar in all groups and only just below normal levels for our
The present study demonstrated that senescent rat hearts laboratory (23.460.8 and 33.961.6 mmol / g dry weight had reduced baseline levels of work, oxygen consumption respectively). The only effect of CoQ treatment in young and efficiency, and were less tolerant to pacing stress than 10 and senescent rats was a small increase in ADP and AMP young hearts. Second, pre-treatment of senescent animals (P,0.05) ( Table 1) .
with CoQ improved the baseline levels of myocardial 10 work, MVO and efficiency prior to the onset of pacing augmenting myocardial pump function was caused not by 2 and produced a marked improvement in recovery of all the direct action of CoQ on the myocytes, but via a 10 three functional parameters after pacing. In these terms, the vasodilator effect of CoQ on the coronary vasculature 10 performance of hearts of CoQ -treated senescent rats was which improved coronary flow reserve and which itself 10 restored to that of young animals. Moreover, there was no increased myocardial contractility (Gregg effect) [28] . We significant improvement in cardiac function of young rats believe that this is unlikely to be a major mechanism, for treated with CoQ compared to that of untreated young the following reasons: (1) The increases in coronary flow 10 rats. We discuss below technical aspects of the study and and MVO observed in the hearts of CoQ -treated rats
the interpretation of our data in physiological and bioduring post-pacing recovery (Figs. 3 and 4) are all chemical terms.
explicable simply in terms of the increased demand for oxygen created by increased work output by the heart; (2) There is evidence that the direct effect of CoQ on 10 
Experimental preparation: comparison of old and vascular smooth muscle is vasoconstriction rather than young rats
vasodilation [29] ; (3) The enhanced pump function in the hearts of CoQ -treated animals was evident even in the 10 The senescent rats had hypertrophic hearts with a greater pre-pacing period (Fig. 1) at a time when the coronary mass than the young rats. The systolic blood pressure flow in the treated and untreated senescent hearts was very measured in the awake state using the tail cuff method was similar (Fig. 3 ). All these considerations strongly suggest a actually lower in the senescent rats than in the young rats.
direct action of CoQ on the senescent myocyte to 10 Thus the mild cardiac hypertrophy in the senescent hearts enhance ATP production (as evidenced by increased was a consequence of age and not hypertension.
MVO ) which is most evident after a period of increased 2 The pacing stress protocol used here was designed to energy demand induced by aerobic pacing stress. stress mitochondria by maximizing myocardial oxygen consumption and thus oxidative phosphorylation, without 4.3. The senescent myocardium and mitochondrial producing ischemia. In order to avoid subendocardial decline ischemia in the pacing period, we perfused the heart in Langendorff mode at a greater pressure, (96 mmHg) than A by-product of the process of oxidative phosphorylais usually used in this preparation (74 mmHg) [21] . To tion is a small but significant flow of oxygen free radicals. assess the extent of ischemia produced by pacing, we Most of these reactive oxygen species are scavenged by an measured the release of myocardial lactate into the corarray of endogenous antioxidant enzymes, principally onary effluent. In response to the aerobic stress the release superoxide dismutase, catalase, and glutathione peroxidase of lactate increased minimally in both groups, thus validat- [30] . Nevertheless a proportion of free radicals escapes this ing the aerobic nature of the pacing stress.
protective process and causes injury principally in the Because of the slower pre-pacing native heart rate in the mitochondria, the targets for damage including membrane senescent (21264 bpm) than in the young hearts (27265 lipids, DNA, and proteins [31] . There is evidence that the bpm), the increase in heart rate by pacing to the same high activity of endogenous oxygen free radical scavenger level (510 bpm) in both groups represented a greater systems is altered in senescent tissues [32] . With increased proportional increase in rate in the senescent (58%) than in age, the mitochondrial resting respiratory rate and the the young hearts (47%). This could have represented a production of reactive oxygen species are significantly greater level of aerobic stress in the older hearts, although elevated in a number of tissues, including the heart [32] . as we have shown, this rate did not cause ischemia.
As a consequence, despite advancing age, the intrinsic However, in the untreated senescent hearts the standard enzymic protective mechanisms against oxidative stress pacing rate of 510 bpm evoked a much lower level of and the presence of endogenous antioxidant molecular myocardial oxygen consumption in the senescent hearts species, there is an accumulation of oxidatively damaged than in the young hearts and therefore actually represented macromolecules in the cell, and particularly in the mitoa lower level of aerobic stress in the senescent hearts (Fig. chondria [31] . 4). Even with this lower level of stress, recovery of pump A key target for these reactive oxygen species is function after pacing in the untreated senescent hearts mitochondrial DNA, which contains a set of genes exclu-(17%) was much less than in the young hearts (45%) (Fig. sively involved in mitochondrial energy production. Dur-2).
ing the aging process there is a progressive accumulation of mitochondrial DNA mutations which may contribute to 4.2. Effect of CoQ treatment on cardiac function a concomitant decrease in the capacity of senescent cells 10 and tissues to produce energy by oxidative phosphorylation Since coronary flow in the treated senescent hearts was [12, [14] [15] [16] 18, [33] [34] [35] . Unlike the nucleus, the mitochondrgreater both during pacing and during the post-pacing ion has a relatively inefficient DNA repair system. Furtherperiod it might be postulated that the action of CoQ in more the damaged mitochondrial DNA and its resultant phorylation function in the senescent rat heart would mitochondrial membrane as a function of increasing age in therefore seem warranted. mammals [39] . Correction of this deficit may therefore account, at least in part, for the efficacy of exogenous 4. 4 
. Biochemical considerations of the effects of CoQ
CoQ in ameliorating senescent myocardial dysfunction. 10 10 Finally, CoQ is known to have an antioxidant effect 10 We found that senescent hearts showed reduced reand thus could help the endogenous protective enzyme covery of pump function and efficiency compared to young systems ''mop up'' excess reactive oxygen species and hearts. We have shown for the first time that administration prevent the accumulation of damaged cellular components, of CoQ to senescent rats ameliorates these functional leading to functional loss, which appears to accumulate 10 deficits. However the mechanism of this age-specific effect throughout life [12, 18, 40] . But this would not be expected is not clear. One possible explanation is that the direct to be effective in the relatively short periods of the present action of CoQ as a redox substrate in the mitochondria experiments, in which CoQ was administered for 6 10 10 significantly increases the energy output from oxidative weeks prior to cardiac function tests. Furthermore, the phosphorylation in the myocardium by promoting coupled aerobic stress of rapid pacing would be expected to electron flow. This would improve the efficiency of ATP generate fewer oxygen free radicals than ischemia / reperfuproduction through increased electron flow along the sion stress which is the usual setting in which the respiratory chain. The provision of additional CoQ , itself cardioprotective effects of antioxidants are seen. Whilst we 10 a naturally occurring redox compound integral to respiratocannot yet eliminate the possibility of a cellular repair ry chain function as a mobile lipophilic redox carrier, process which reduces the abundance of oxidatively damwould increase the throughput of redox reactions that lead aged target molecules (such as proteins or lipids) during to reoxidation of NADH in mitochondria by consumption the 6 weeks of CoQ treatment, we suggest that anti-10 of molecular oxygen. Thus ATP production for cardiac oxidant effects alone of CoQ do not provide a compel-10 contractile function would be increased. We measured only ling explanation of its efficacy in the present study. static levels of myocardial ATP after recovery from pacing and found essentially normal values in all groups, and no 4.5. Potential clinical implications effect of CoQ . To analyse the rate of ATP production 10 and the stimulatory effect of CoQ would require detailed As there were no detrimental effects of treatment 10 studies of mitochondrial bioenergetic parameters including observed in young or old animals, and intake of CoQ is 10 mitochondrial respiration and the rate and efficiency of simple, our findings in the rat suggest that this compound oxidative phosphorylation. Moreover, ATP or DG meamay be able to improve the tolerance of the human ATP surements using magnetic resonance spectroscopy would senescent myocardium to stress. Although further studies be valuable.
in animals are indicated, the clinical relevance of these It has been reported that the membrane potential in findings for elderly patients is that CoQ may have a 10 mitochondria of rat hearts declines with age [20] . The cardioprotective action in certain circumstances such as membrane potential, measured by use of the indicator dye during the stress associated with myocardial infarction and oxonol VI in isolated mitochondria, is a substantial comcardiac surgery where increased energy demands need to ponent of the proton motive force whereby the energy be met for sustained cardiac viability. from respiratory electron transport is harnessed chemiosmotically for synthesis of ATP. Moreover, reduced membrane potential in cardiac mitochondria of bioenergetically 5. Conclusion compromised rats is ameliorated by the addition of CoQ 10 and some analogous quinones [20] , which is further
We conclude that pre-treatment with CoQ improves 10 evidence of a direct effect of CoQ on the mitochondrial the tolerance of the senescent myocardium to aerobic 10 bioenergetic system. Measurement of the oxidative phosstress. The evidence presented here suggests an action at phorylation function of the hearts of senescent rats, with or the myocyte level rather than on the coronary vasculature. without CoQ treatment, would provide further inforWe propose that the effects of CoQ seen here are not 10 10 mation on this point. merely those of a free radical scavenger, but that this redox Another possible enzymatic target for CoQ is the compound promotes restoration of electron flow in 
